Completed

2

64

Europe

Vargatef, EMEA/H/C/002569, Tablet, Powder for infusion, Concentrate for solution for infusion, Powder for solution for injection/infusion, Powder for injection, Solution for infusion, , Capsule, Suspension for injection, Powder for concentrate for solution for injection/infusion, Concentrate for solution for injection/infusion, Capsule, soft, Concentrate for solution for injection, Concentrate and solvent for solution for injection/infusion, Powder for solution for infusion, Implant, Kit for radiopharmaceutical preparation, Capsule, hard, Solution for injection/infusion, Powder and solvent for solution for injection, Solution for injection in pre-filled syringe, Concentrate and solvent for solution for infusion, Powder for solution for injection, Powder and solvent for solution for injection in pre-filled syringe, Concentrate and solvent for concentrate for solution for infusion, Solution for injection, Zytiga, Kadcyla, Giotrif, Arimidex, Trisenox, Erwinase, Inlyta, Vidaza, Levact, Avastin, Bleomycin, Velcade, Bosulif, Adcetris, Jevtana, Xeloda, Carboplatin, Erbitux, Leukeran, Cisplatin, Evoltra, Xalkori, Endoxan powder and capsule, Alexan and Cytarabin, Tafinlar, DepoCyte, Dacarbazin Lipomed, Sprycel, Daunoblastin, Dacogen, Firmagon, Docetaxel and Taxotere, Myocet, Caelyx, Epirubicin and Farmorubicin, Xtandi, Halaven, Tarceva, Etoposid concentrate and Vepesid capsule, Afinitor, Exemestan and Aromasin, Faslodex, Neoflubin, 5-Fluorouracil "Ebewe", Iressa, Gemzar, Zoladex, Zevalin, Imbruvica, Holoxan, Glivec, IntronA, Yervoy, Irinotecan, Tyverb, Revlimid, Femara, Calciumfolinat, Eligard Depot and Trenantone, Puri-Nethol and Xaluprine suspension, Methotrexat "Lederle" and Ebetrexat, Methotrexat and Ebetrexat, Metoject PEN and Ebetrexat and Methotrexat, Mitomycin C, Tasigna, Gazyvaro, Arzerra, Eloxatin and Ebeoxal and Oxaliplatin, Abraxane and Ebetaxel and Paclitaxel, Vectibix, Votrient, PegIntron and ViraferonPeg, PegIntron and ViraferonPeg injector, Alimta, Perjeta, Imnovid, Iclusig, Fortecortin and Aprednislon, Stivarga, MabThera, Jakavi, Nexavar, Sutent, Nolvadex, Temozolomide SUN, Torisel, Thalidomide, Hycamitin, Fareston, Mekinist, Herceptin and Kadcyla, Zelboraf, Velbe, Oncovin and Vincristin, Navelbine and Eberelbin, Zaltrap, Vargatef

Medical University of Graz, Medical University of Graz

Patients with locally advanced and/ or metastasized carcinoma for whom no further evidence-based drug treatment is established.A progression of the tumor is confirmed due to the last evidence-based drug therapy. Due to circulating tumor-DNA (ctDNA) in a blood sample and/or tissue sample of metastasis, a molecular-biologic tumor profiling is performed and an adapted tumor-specific drug therapy is selected., Patients with locally advanced and/ or metastasized carcinoma for whom no further evidence-based drug treatment is established., Diseases [C] - Cancer [C04]